President Donald Trump, joined by members of the pharmaceutical industry and administration officials, delivers remarks on lowering drug prices in the Oval Office at the White House in Washington, DC, on Nov. 6, 2025. Andrew Harnik/Getty Images
Americans will have access to Zepbound and Wegovy at reduced prices starting in 2026.
The wildly popular treatments for diabetes and obesity will be available to consumers at a nearly 90 percent discount in January, under an agreement negotiated by the Trump administration with Eli Lilly and Novo Nordisk.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Original News Source Link – Epoch Times
Running For Office? Conservative Campaign Consulting – Election Day Strategies!